Companies /Healthcare

AMGEN Inc

NASDAQ: AMGN Drug Manufacturers - General
$377.35
▼ $5.12 (−1.34%) today
Markets closed · 4:51pm ET

AMGN Coverage

Page 48
7:35am ET
Investing

Pre-Market Stock News (August 16, 2007)

(AMGN) Amgen announced 12-14% layoffs and lowered guidance for 2007.(ANX) ADVENTRX Pharma announces fast track designation granted by the FDA for CoFactor for treatment of metastatic colorectal cancer.(AUXL) Auxilium Pharma receivef FDA…

Douglas A. McIntyre
4:07pm ET
Health and Healthcare

Amgen Moves From Biotech to Big Pharma, With More Baggage

Amgen Inc. (NASDAQ:AMGN) did what Wall Street thought it would in its after-the-bell conference call.  The biotech giant announced layoffs to the tune 12% to 14% of its workforce, which translates to…

Douglas A. McIntyre
6:06am ET
Investing

Amgen’s (AMGN) Troubled Quarter

Amgen (AMGN) actually rallied a bit after hours yesterday. But, revenue growth was hard to come by. Amgen reported net income of $1.02 billion, or 90 cents per share, for the quarter…

Douglas A. McIntyre
3:30am ET
Investing

Nasdaq Short Interest For July

Below is the short interest for key Nasdaq stocks for July, The figures compare July 13 with June 15. 2007. Company                                 Short…

Douglas A. McIntyre
6:49am ET
Investing

Pre-Market Analyst Calls (July 23, 2007)

AFL raised to Overweight at Lehman.AMGN raised to Hold at Citigroup.ASBC cut to Underweight at Lehman.BUD raised to Hold at Citigroup.CKR started as Neutral at JPMorgan.EMN raised to Buy at Citigroup.EOG cut…

Douglas A. McIntyre
7:07am ET
Investing

Pre-Market Stock News (July 12, 2007)

(AA) Alcoa trading up 6% after Rio Tinto gave a higher rival bid over Alcoa’s buyout offer for Alcan.(AAON) AAON announced a 3 for 2 stock split.(AL) Alcan gets a rival $38.1…

Douglas A. McIntyre
8:07pm ET
Investing

Nasdaq Short Interest, June 2007

Below are the major short interest positions for stocks traded on Nasdaq for the period ending June 15 compared to comparable numbers for May. Company                      …

Douglas A. McIntyre
6:29am ET
Investing

Earlybird Analyst Calls (June 14, 2007)

ACL started as Buy at Jefferies.AMGN started as Mkt Perform at Rodman & Renshaw.B started as Outperform at CIBC.CBB started as Buy at UBS.CHE started as Buy at Jefferies.CTL raised to Neutral…

Douglas A. McIntyre
10:08pm ET
Health and Healthcare

Amgen Buys Ilypsa, Diversification Via Acquisition

Amgen (AMGN) is paying a hefty sum to diversify its Aranesp and Epogen franchises.  The company is acquiring developmental-stage Ilypsa, a biotech company based in San Francisco that focuses on kidney disease…

Douglas A. McIntyre
6:30pm ET
Health and Healthcare

Biotechs & Pharmas Bracing For ASCO Annual Meeting

This weekend we have the mother of all future cancer treatment conferences: ASCO, or The American Society of Clinical Oncology.  Cancer stocks in the last few weeks have been seeing a muted…

Douglas A. McIntyre